Liposome-Based Drug Delivery Systems in Cancer Immunotherapy

Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such as liposomes, have favorable advantages with the potential to further improve cancer immunotherapy and even stronger immune responses by improving cell type-specific delivery and enhancing drug efficacy. Liposomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zili, Da Silva, Candido G., Van der Maaden, Koen, Ossendorp, Ferry, Cruz, Luis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694212/
https://www.ncbi.nlm.nih.gov/pubmed/33158166
http://dx.doi.org/10.3390/pharmaceutics12111054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694212/
https://www.ncbi.nlm.nih.gov/pubmed/33158166
http://dx.doi.org/10.3390/pharmaceutics12111054

Ejemplares similares